TELSARTAN PLUS Tablet Price in Pakistan

View latest Price, manufacturer, formulation, and pack details of TELSARTAN PLUS Tablet.

Available Products of TELSARTAN PLUS Tablet

TELSARTAN PLUS Tablet 14's

Reg#: 093973

Description of TELSARTAN PLUS Tablet

Each tablet containsTelmisartan ….......40mg Hyydrochlorothiazide…........ 12.5mg

Medicine Info

Pack Size: 14's

Company: CCL Pharmaceutical Pvt. Ltd.

Price of TELSARTAN PLUS Tablet

Price: Rs. 530.56

Related Keywords

  • TELSARTAN PLUS Tablet price in Pakistan
  • TELSARTAN PLUS Tablet tablet price
  • TELSARTAN PLUS Tablet Capsule price
  • CCL Pharmaceutical Pvt. Ltd. TELSARTAN PLUS Tablet price
  • Buy TELSARTAN PLUS Tablet online
  • TELSARTAN PLUS Tablet 40mg uses
  • TELSARTAN PLUS Tablet syrup price
  • TELSARTAN PLUS Tablet pack 14's cost

TELSARTAN PLUS Tablet 28's

Reg#: 093973

Description of TELSARTAN PLUS Tablet

Each tablet containsTelmisartan ….......40mg Hyydrochlorothiazide…........ 12.5mg

Medicine Info

Pack Size: 28's

Company: CCL Pharmaceutical Pvt. Ltd.

Price of TELSARTAN PLUS Tablet

Price: Rs. 1008.08

Related Keywords

  • TELSARTAN PLUS Tablet price in Pakistan
  • TELSARTAN PLUS Tablet tablet price
  • TELSARTAN PLUS Tablet Capsule price
  • CCL Pharmaceutical Pvt. Ltd. TELSARTAN PLUS Tablet price
  • Buy TELSARTAN PLUS Tablet online
  • TELSARTAN PLUS Tablet 40mg uses
  • TELSARTAN PLUS Tablet syrup price
  • TELSARTAN PLUS Tablet pack 28's cost

Alternatives brands of TELSARTAN PLUS Tablet

Explore alternative brands for TELSARTAN PLUS Tablet below.

View Alternatives

Explore More Medicines

TELSARTAN PLUS 80:12.5Tablet

CCL Pharmaceutical Pvt. Ltd.

MRP: Rs. 1899.7759

TENSORETICTablets

CCL Pharmaceutical Pvt. Ltd.

MRP: Rs. 369.6640

BACTCIDInjection

CCL Pharmaceutical Pvt. Ltd.

MRP: Rs. 394.4266

CEF-OD DSSusp

CCL Pharmaceutical Pvt. Ltd.

MRP: Rs. 349.1257

CEF-OD DSSusp

CCL Pharmaceutical Pvt. Ltd.

MRP: Rs. 684.2697

We’d love to hear your thoughts!

Share your comment below and join the conversation ✨

Comments

No comments yet. Be the first!